PA
SANA icon

Pineridge Advisors’s Sana Biotechnology SANA Stock Holding History

Pineridge Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$710 Buy
+200
New +$723 ﹤0.01% 407

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pineridge Advisors's SANA Position: Q3 2025 in Review

Pineridge Advisors opened a new position in Sana Biotechnology (SANA) in Q3 2025: 200 shares worth $710. The stake represents ﹤0.01% of the portfolio and ranks #407 among its holdings.

178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

  • Pineridge Advisors held 200 shares of Sana Biotechnology worth $710 as of Q3 2025.
  • Sana Biotechnology was a new Pineridge Advisors position in Q3 2025.
  • Sana Biotechnology made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #407 holding.
  • 178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.